Jeil Bevegron Tablets 50 mg
Vibegron 50mg
Tablet · Prescription medication
Jeil Health Science Co., Ltd.
MFDS item code 202502086 · Approved 2025.08.13
Treatment of symptoms of overactive bladder (urinary urgency, frequent urination, etc.)
This medication is used to treat symptoms of urgency, frequency, and urge incontinence caused by overactive bladder. Patients should understand that this medication helps alleviate symptoms by controlling excessive contractions of the bladder. Improvement in these symptoms will reduce discomfort in daily life. Consistent use is effective in symptom management. Therefore, it is used for the improvement of overactive bladder symptoms.
Adults: Administer 50mg of vibegron orally once daily after a meal.
This medication should not be used by those who are allergic to this drug or any of its ingredients. Also, since this medication contains lactose, individuals with genetic disorders that impede lactose digestion should not take it. Those with severe heart disease should be cautious as symptoms may worsen with this medication. Individuals with impaired liver or kidney function may be at risk for increased blood concentration of this medication, so it should be used carefully. Patients with prolonged QT interval related to heart rhythm should also exercise caution when using this medication. Those with bladder outlet obstruction may experience difficulties in urination following medication use, thus should be cautious. Constipation or dry mouth may occur during the use of this medication. Neurological symptoms such as headache, dizziness, insomnia, and drowsiness may also arise. Gastrointestinal issues such as dyspepsia, abdominal pain, and diarrhea have also been reported. Skin rashes, itching, photophobia, and dry eyes can also present as side effects. Signs of liver dysfunction may appear, so periodic testing may be necessary. Before taking this medication, it is imperative to check for similar symptoms in other conditions, such as urinary tract infections or bladder cancer. Particularly, if there are symptoms of impaired urination, immediate consultation with medical professionals is recommended, and the medication should be stopped if necessary. This medication can interact with other drugs; thus, caution is necessary, especially when taken alongside drugs that inhibit or activate enzymes that metabolize drugs in the liver. Women who are pregnant or may become pregnant should carefully consider the benefits and risks before taking this medication. If breastfeeding, it also needs to be considered that this medication can be transmitted through breast milk, so careful decision-making regarding continuing breastfeeding is essential. It is advisable not to use this medication in children as safety and efficacy have not been established. Elderly patients may have decreased physiological functions, requiring careful monitoring and cautious use. In cases of overdose, monitoring heart rate, blood pressure, and electrocardiogram status is necessary, along with appropriate treatment based on symptoms. This medication should be stored out of reach of children and should not be transferred to other containers.
Not everyone experiences these, and they can vary from person to person.
This medication may be sensitive to air or moisture; thus, it must be stored in a well-closed container. It is important to maintain a storage temperature between 1 and 30 degrees Celsius.
Light green round film-coated tablets
30 tablets/box [10 tablets/Alu-Alu X 3]
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.